127 related articles for article (PubMed ID: 14508371)
1. Life-threatening veno-occlusive disease after living-related liver transplantation.
Ben-Ari Z
Transplantation; 2003 Sep; 76(6):1007. PubMed ID: 14508371
[No Abstract] [Full Text] [Related]
2. Life-threatening veno-occlusive disease after living-related liver transplantation.
Nakazawa Y; Chisuwa H; Mita A; Ikegami T; Hashikura Y; Terada M; Nakayama J; Kawasaki S
Transplantation; 2003 Mar; 75(5):727-30. PubMed ID: 12640317
[TBL] [Abstract][Full Text] [Related]
3. Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease.
Palladino M; Miele L; Pompili M; Forgione A; Vellone V; Vecchio FM; Chiusolo P; Laurenti L; Gasbarrini G; Sica S; Grieco A
Clin Transplant; 2008; 22(6):837-41. PubMed ID: 18713263
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Outcome of Veno-Occlusive Disease After Liver Transplant: A Retrospective Single-Center Experience.
Patrono D; Marola S; David E; Chiusa L; Martini S; Mirabella S; Lupo F; Salizzoni M; Romagnoli R
Exp Clin Transplant; 2019 Apr; 17(2):214-221. PubMed ID: 30381049
[TBL] [Abstract][Full Text] [Related]
5. Optimal approach to prevent veno-occlusive disease following hematopoietic stem cell transplantation in children.
Hassan Z
Pediatr Transplant; 2010 Sep; 14(6):683-7. PubMed ID: 20353406
[No Abstract] [Full Text] [Related]
6. Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.
Corbacioglu S; Kernan N; Lehmann L; Brochstein J; Revta C; Grupp S; Martin P; Richardson PG
Expert Rev Hematol; 2012 Jun; 5(3):291-302. PubMed ID: 22780209
[TBL] [Abstract][Full Text] [Related]
7. Late-onset hepatic veno-occlusive disease post autologous peripheral stem cell transplantation successfully treated with oral defibrotide.
Shah MS; Jeevangi NK; Joshi A; Khattry N
J Cancer Res Ther; 2009; 5(4):312-4. PubMed ID: 20160371
[TBL] [Abstract][Full Text] [Related]
8. Successful defibrotide treatment of a patient with veno-occlusive disease after living-donor liver transplantation: A case report.
Lee TB; Yang K; Ko HJ; Shim JR; Choi BH; Lee JH; Ryu JH
Medicine (Baltimore); 2021 Jun; 100(25):e26463. PubMed ID: 34160449
[TBL] [Abstract][Full Text] [Related]
9. Defibrotide Use in Vincristine-induced Hepatic Sinusoidal Obstruction Syndrome.
Tang C; Lindsay J; Gill A; Kerridge I
Clin Lymphoma Myeloma Leuk; 2017 Aug; 17(8):539-541. PubMed ID: 28842141
[No Abstract] [Full Text] [Related]
10. Early graft failure due to a veno-occlusive disease after a pediatric living donor liver transplantation.
Izaki T; Inomata Y; Asonuma K; Okajima H; Ohshiro H; Ueno M; Hamamoto R; Iyama K; Tanaka K
Pediatr Transplant; 2004 Jun; 8(3):301-4. PubMed ID: 15176969
[TBL] [Abstract][Full Text] [Related]
11. Defibrotide for the treatment of veno-occlusive disease after liver transplantation.
Mor E; Pappo O; Bar-Nathan N; Shaharabani E; Shapira Z; Tur-Kaspa R; Ben-Ari Z
Transplantation; 2001 Oct; 72(7):1237-40. PubMed ID: 11602848
[TBL] [Abstract][Full Text] [Related]
12. Defibrotide for hepatic VOD in children: exact statistics can help!
Ammann RA
Bone Marrow Transplant; 2004 Aug; 34(3):277-8. PubMed ID: 15170162
[No Abstract] [Full Text] [Related]
13. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies.
Ho VT; Revta C; Richardson PG
Bone Marrow Transplant; 2008 Feb; 41(3):229-37. PubMed ID: 17994121
[TBL] [Abstract][Full Text] [Related]
14. Prophylaxis and treatment of hepatic veno-occlusive disease after pediatric stem cell transplantation.
Tsakiris DA
Haematologica; 2006 Jun; 91(6):726B. PubMed ID: 16769572
[No Abstract] [Full Text] [Related]
15. Defibrotide as salvage therapy for refractory veno-occlusive disease of the liver complicating allogeneic bone marrow transplantation.
Abecasis MM; Conceição Silva JP; Ferreira I; Guimarães A; Machado A
Bone Marrow Transplant; 1999 Apr; 23(8):843-6. PubMed ID: 10231151
[TBL] [Abstract][Full Text] [Related]
16. Incidence and management of hepatic severe veno-occlusive disease in 273 patients in a single centre with defibrotide.
Pol RR; Russell N; Das-Gupta E; Watson L; Rachael L; Byrne J
Bone Marrow Transplant; 2016 Sep; 51(9):1262-4. PubMed ID: 27111044
[No Abstract] [Full Text] [Related]
17. Successful therapy of transplant-associated veno-occlusive disease with a combination of tissue plasminogen activator and defibrotide.
Jenner MJ; Micallef IN; Rohatiner AZ; Kelsey SM; Newland AC; Cavenagh JD
Med Oncol; 2000 Nov; 17(4):333-6. PubMed ID: 11114714
[TBL] [Abstract][Full Text] [Related]
18. In brief: Defibrotide (Defitelio) for hepatic veno-occlusive disease.
Med Lett Drugs Ther; 2016 Sep; 58(1503):120. PubMed ID: 27603963
[No Abstract] [Full Text] [Related]
19. Long-awaited news for hepatic veno-occlusive disease.
Arai S
Blood; 2016 Mar; 127(13):1630-1. PubMed ID: 27034420
[TBL] [Abstract][Full Text] [Related]
20. Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children.
Qureshi A; Marshall L; Lancaster D
Pediatr Blood Cancer; 2008 Apr; 50(4):831-2. PubMed ID: 18286502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
